Improvement of Tolerability and Adverse Events Occurrence during Treatment with Dasatinib Used on a Compassionate Basis in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) / Martino, B; Rege Cambrin, G; Gozzini, A; Stagno, F; Breccia, M; Specchia, G; Orlandi, E; Pungolino, E; Falzetti, F; Galimberti, S; Fava, C; Marino, A; Nobile, F. - In: BLOOD. - ISSN 0006-4971. - 110:(2007). (Intervento presentato al convegno ASH).
Improvement of Tolerability and Adverse Events Occurrence during Treatment with Dasatinib Used on a Compassionate Basis in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Breccia M;
2007
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
